Nitric oxide (NO) is a gaseous mediator that–apart from its vasodilatatory properties–has various effects on inflammation [32,33] and vascular endothelial growth factor (VEGF)-mediated tissue remodeling [34], both possibly modifying the development of BPD. The gene discussed is VEGFA; the disease is bronchopulmonary dysplasia.